FindTrial
Sign In

Intervention/treatment

DEVICE5 trials

Sponsors

Abbott Medical Devices, Beijing Chest Hospital, Clarkson University, Centre hospitalier de l'Université de Montréal (CHUM), Synaptrix Labs Inc.

Conditions

Amyotrophic Lateral SclerosisBradycardiaCaffeineCervical Spinal Cord InjuryEndogenous Cushing SyndromeNSCLC Stage IIIBNSCLC Stage IVNeurologic Disorder

Phase 4

Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's Syndrome
NCT06131580
Centre hospitalier de l'Université de Montréal (CHUM)Endogenous Cushing Syndrome
Start: 2023-10-24End: 2025-11-24Updated: 2023-11-14

Unknown Phase

Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)
CompletedNCT00311168
Abbott Medical DevicesBradycardia
Start: 2006-02-28End: 2008-09-30Updated: 2021-08-12
Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory Study
NCT03594682
Beijing Chest HospitalNSCLC Stage IIIB, NSCLC Stage IV
Start: 2018-08-31End: 2020-07-31Target: 31Updated: 2018-07-20
The Effects of e+Shots Energy Beverage on Mental Energy
CompletedNCT03850275
Clarkson UniversityCaffeine
Start: 2015-09-26End: 2016-12-15Updated: 2021-08-02
EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis
Not yet recruitingNCT06169696
Synaptrix Labs Inc.Amyotrophic Lateral Sclerosis, Cervical Spinal Cord Injury, Neurologic Disorder +5
Start: 2024-11-30End: 2025-01-31Target: 6Updated: 2024-01-18

Related Papers

7236 Long Term Extension of Osilodrostat Therapy in Canadian Patients with Cushing’s Disease Benefiting from the LINC 3 and LINC 4 Studies
Journal of the Endocrine Society2024-10-01